Properties
What is it?
International Nonproprietary Name - CARBOCISTEINE Active Substance: CARBOCISTEINE Clinical-Pharmacological Group: Mucolytic Agent Composition and Dosage Form: Syrup 5% for Adults: 125 ml bottle 100 ml Carbocisteine ......... 5.0 g Excipients: Methylparahydroxybenzoate 0.15 g. Sucrose (35 g/100 ml), Caramel flavor, Glycerol, Patent Blue V, Sunset Yellow S, Sodium Hydroxide, Distilled Water. Syrup 2% for Children: 125 ml bottle 100 ml Carbocisteine ........... 2.0 g Excipients: Methylparahydroxybenzoate 0.15 g Sucrose (70 g/100 ml) Banana flavor, Glycerol, Sunset Yellow S, Sodium Hydroxide, Distilled Water. Indications: For the treatment of acute and chronic obstructive diseases of the respiratory tract with pathological thick mucus secretion in children and adults (acute bronchitis, chronic bronchitis in the exacerbation phase, pneumonia, bronchial asthma, bronchopneumonia, bronchiectatic disease, otitis media, rhinitis, sinusitis). Dosage and Administration: Fluditec 5% syrup is prescribed for adults and children over 12 years of age, one tablespoon 3 times a day after meals. Fluditec 2% syrup is prescribed for children under 12 years of age: - In newborns and children up to 2 years of age, the daily dose of Fluditec is 20-30 mg/kg body weight, i.e., 1 teaspoon (5 ml) once a day after meals. An overdose of 100 mg/day is not recommended. - In children aged 2-5 years, the daily dose of Fluditec is 200 mg, i.e., 1 teaspoon 2 times a day after meals. - In children aged 5-12 years, the daily dose of Fluditec is 300 mg, i.e., 1 teaspoon 3 times a day after meals. The duration of treatment, as a rule, should not exceed 8-10 days. Side Effects: Gastrointestinal: Possible abdominal pain, vomiting, diarrhea. In such cases, reducing the dose of the preparation is recommended. Contraindications: * Hypersensitivity to the preparation or its ingredients (including methylparahydroxybenzoate and other parahydroxybenzoates) in the anamnesis. Pregnancy and Lactation: During pregnancy, the administration of the preparation is possible only when the beneficial effect for the mother clearly outweighs the potential risk to the fetus (from the second trimester of pregnancy). Special Instructions: ◄ The use of Fluditec with antitussive preparations and/or substances that suppress bronchial secretion is not recommended (including atropine-like substances). For patients with diabetes mellitus and those on a low-sugar diet, the sucrose content in the preparation should be taken into account (1 tablespoon of 5% syrup for adults contains 5.25 g of sucrose, 1 teaspoon of 2% syrup for children contains 3.5 g of sucrose). ◄ Fluditec should be prescribed with particular caution to individuals with cystitis and chronic glomerulonephritis in the exacerbation phase, as well as to individuals with gastric and duodenal ulcer diseases. ◄ Fluditec should be prescribed with particular caution to individuals with excessive purulent sputum. Overdose: Symptoms: Abdominal pain, vomiting, diarrhea. Treatment: Symptomatic. Interactions with Other Drugs: Not described.